These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 16545437

  • 1. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T.
    Gynecol Oncol; 2006 Oct; 103(1):155-9. PubMed ID: 16545437
    [Abstract] [Full Text] [Related]

  • 2. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T, Radiation Therapy Oncology Group.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):168-73. PubMed ID: 15093913
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
    Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S.
    Gynecol Oncol; 2005 Jan 01; 96(1):198-203. PubMed ID: 15589601
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.
    Gynecol Oncol; 2005 Apr 01; 97(1):126-35. PubMed ID: 15790448
    [Abstract] [Full Text] [Related]

  • 7. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.
    Gynecol Oncol; 2006 Oct 01; 103(1):87-93. PubMed ID: 16545441
    [Abstract] [Full Text] [Related]

  • 8. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
    Citron JR, Sutton H, Yamada SD, Mehta N, Mundt AJ.
    Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1432-8. PubMed ID: 15275729
    [Abstract] [Full Text] [Related]

  • 9. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR.
    Anticancer Res; 2000 Aug 01; 20(3B):1977-84. PubMed ID: 10928137
    [Abstract] [Full Text] [Related]

  • 10. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM, Venkatraman E, Chi DS, Barakat RR.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):111-7. PubMed ID: 15850910
    [Abstract] [Full Text] [Related]

  • 11. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
    Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, Kudo R, Japanese Gynecologic Oncology Group.
    Gynecol Oncol; 2008 Jan 01; 108(1):226-33. PubMed ID: 17996926
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients.
    Bruzzone M, Miglietta L, Franzone P, Gadducci A, Boccardo F.
    Gynecol Oncol; 2004 May 01; 93(2):345-52. PubMed ID: 15099944
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
    Aoki Y, Watanabe M, Amikura T, Obata H, Sekine M, Yahata T, Fujita K, Tanaka K.
    Gynecol Oncol; 2004 Aug 01; 94(2):333-9. PubMed ID: 15297170
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: a Gynecologic Oncology Group study.
    McMeekin DS, Walker JL, Hartenbach EM, Bookman MA, Koh WJ, Gynecologic Oncology Group.
    Gynecol Oncol; 2009 Jan 01; 112(1):134-41. PubMed ID: 18962846
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
    Milgrom SA, Kollmeier MA, Abu-Rustum NR, Tew WP, Sonoda Y, Barakat RR, Alektiar KM.
    Gynecol Oncol; 2013 Sep 01; 130(3):436-40. PubMed ID: 23800696
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.